Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Kallikrein
Introduction
Kallikreins (tissue and plasma kallikrein) are a subgroup of the serine protease family.
Functions
Functions
They liberate kinins (BK and KD) from the kininogens.[1]
It also generates plasmin from plasminogen:
Prekallikrein is the precursor of plasma kallikrein. It can only activate kinins after being activated itself by factor XII or other stimuli.
Genes
Genes
There are 15 known kallikreins: KLK1, KLK2, KLK3, KLK4, KLK5, KLK6, KLK7, KLK8, KLK9, KLK10, KLK11, KLK12, KLK13, KLK14, KLK15
Clinical significance
Clinical significance
Kallikreins are targets of active investigation by drug researchers as possible biomarkers for cancer.[2][3]
Prostate-specific antigen (PSA; hk3, human kallikrein gene 3) and human glandular kallikrein (hK2) are used as tumor markers for prostate cancer.
References
References
- ↑ Oikonomopoulou, K., Hansen, K.K., Saifeddine, M., Tea, I., Blaber, M., Blaber, S.I., Scarisbrick, I., Andrade-Gordon, P., Cottrell, G.S., Bunnett, N.W., Diamandis, E.P., and Hollenberg, M.D. “Proteinase-activated receptors, targets for kallikrein signaling” Journal of Biological Chemistry. 281: 32095-112, 2006.
- ↑ Borgono, C.A., and Diamandis, E.P. “The emerging roles of human tissue kallikreins in cancer” Nature Reviews Cancer 4: 876-90, 2004.
- ↑ Diamandis, E.P., and Yousef, G.M. “Human Tissue Kallikreins: A Family of New Cancer Biomarkers” Clinical Chemistry 48: 1198-1205, 2002.
External links
External links
- Kallikreins at the US National Library of Medicine Medical Subject Headings (MeSH)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]